
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Hypertensive nephropathy laboratory findings
Introduction
Please help WikiDoc by adding more content here. It’s easy! Click here to learn about editing.
overview
overview
An elevated level of urinary albumin is a helpful diagnostic test for hypertensive nephropathy.
Laboratory Findings
Laboratory Findings
- Blood tests
- High levels of creatinine, BUN
- Anemia: low Hb and hematocrit
- Hyperlipidemia
- Elevated serum levels of β2-microglobulin and transforming growth factor-β (TGF-β) have been recently found to predict the hypertensive nephropathy. [1]
- Urinary analysis
- High protein levels
- May range from microalbuminuria (< 300 mg/ dl) to overt proteinuria (> 300 mg/ dl)
- Urinary albumin to creatinine ratio may be increased.
- microscopic haematuria
- Presence of podocyte proteins in the urine precede proteinuria, so it can be used as an early investigation. But, laboratory test for detecting podocytuia is not widely available. [2]
- Increased mRNA levels of podocin and nephrin in the urine is another early diagnostic test, which shows glomerular damage and developing hypertensive nephropathy. [2]
- High protein levels
References
References
- ↑ Cao, Junjie; Hou, Rui; Lu, Jingqian; Zhang, Kongyan; Zhao, Cui; Jiang, Haisen; Feng, Yumei; Wang, Yiwei (2019). “The predictive value of β2‑MG and TGF‑β for elderly hypertensive nephropathy”. Experimental and Therapeutic Medicine. doi:10.3892/etm.2019.7278. ISSN 1792-0981.
- ↑ 2.0 2.1 Seccia, Teresa M.; Caroccia, Brasilina; Calò, Lorenzo A. (2017). “Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms”. Journal of Hypertension. 35 (2): 205–212. doi:10.1097/HJH.0000000000001170. ISSN 0263-6352.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
